EP Patent

EP2060268A1 — Pharmaceutical compositions for pulmonary or nasal delivery of peptides

Assigned to Novo Nordisk AS · Expires 2009-05-20 · 17y expired

What this patent protects

The invention relates to pharmaceutical compositions for pulmonary or nasal delivery of an amylin peptide and an insulin peptide

USPTO Abstract

The invention relates to pharmaceutical compositions for pulmonary or nasal delivery of an amylin peptide and an insulin peptide

Drugs covered by this patent

Patent Metadata

Patent number
EP2060268A1
Jurisdiction
EP
Classification
—
Expires
2009-05-20
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.